Modern Authentication of Pharmaceuticals Act of 2025

Bill: 119-hr-1060
Sponsor: full_name: Rep. Davis, Donald G. [D-NC-1]
Introduced: 2025-02-06
Policy area: Health
Subjects: Drug safety, medical device, and laboratory regulation

Drug trafficking and controlled substances

Prescription drugs
Latest action: action_date: 2025-02-06
text: Referred to the House Committee on Energy and Commerce.

Summaries:
action_date: 2025-02-06
action_desc: Introduced in House
text: <p><strong>Modern Authentication of Pharmaceuticals Act of 2025</strong></p><p>This bill requires each dose of a pharmaceutical product that is a controlled substance and that is taken orally in solid form (i.e., pills) to include a physical chemical identifier.&nbsp;(Physical chemical identifiers are substances that possess a unique physical or chemical property, such as inks, pigments, flavors, and molecular taggants, that unequivocally identify and authenticate a drug or dosage.) Under the bill, physical chemical identifiers must be included in or on the product and must be machine readable.&nbsp;&nbsp;</p><p>The bill applies to products manufactured beginning five years after the bill's enactment.</p>

tv_txt: I 119th CONGRESS 1st Session H. R. 1060 IN THE HOUSE OF REPRESENTATIVES February 6, 2025 Mr. Davis of North Carolina (for himself, Mr. Rutherford , and Mr. Bacon ) introduced the following bill; which was referred to the Committee on Energy and Commerce A BILL To amend the Federal Food, Drug, and Cosmetic Act to modernize the methods of authenticating controlled substances in the pharmaceutical distribution supply chain, and for other purposes.

1. Short title This Act may be cited as the Modern Authentication of Pharmaceuticals Act of 2025 . 2. Modernizing the authentication of controlled substances in the pharmaceutical distribution supply chain (a) In general Section 582(a)(9) of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 360eee–1(a)(9) ) is amended— (1) in subparagraph (A)(ii), by striking and at the end; (2) by redesignating subparagraph (B) as subparagraph (C); and (3) by inserting after subparagraph (A) the following: (B) a physical chemical identifier shall be included in or on each dose of a product that is— (i) a controlled substance (as defined in section 102 of the Controlled Substances Act); (ii) in solid oral dosage form; and (iii) manufactured on or after the date that is five years after the date of enactment of the Modern Authentication of Pharmaceuticals Act of 2025 ; and . (b) Conforming changes (1) Section 581(14) of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 360eee(14) ) is amended to read as follows: (14) Product identifier The term product identifier means— (A) a standardized graphic that includes, in both human-readable form and on a machine-readable data carrier that conforms to the standards developed by a widely recognized international standards development organization, the standardized numerical identifier, lot number, and expiration date of the product; or (B) a physical chemical identifier, possessing a unique physical or chemical substance or combination of substances, that— (i) is in or on a product; (ii) is machine readable; and (iii) is intended to authenticate the product or a dosage form thereof. . (2) Section 581(28) of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 360eee(28) ) is amended to read as follows: (28) Verification or verify The term verification or verify means— (A) determining whether the product identifier affixed to, or imprinted upon, a package or homogeneous case corresponds to the standardized numerical identifier or lot number and expiration date assigned to the product by the manufacturer or the repackager, as applicable in accordance with section 582; or (B) determining whether a product or a dosage form thereof is authentic using a physical chemical identifier described in paragraph (14)(B). .